{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T17:02:35Z","timestamp":1789405355528,"version":"build-2803163510"},"posted":{"date-parts":[[2025,11,1]]},"group-title":"In Review","reference-count":74,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,10,13]]},"abstract":"<title>Abstract<\/title>\n                <p>\n                  <bold>Aims:<\/bold>\n                  Alzheimer\u2019s disease (AD) is commonly diagnosed when neuronal damage is already established and irreversible. Achieving an accurate differential diagnosis in the preclinical and mild cognitive impairment (MCI) stage is one of the greatest challenges nowadays. Nanotechnological analysis of plasma extracellular vesicles (pEVs) are gaining attention as a promising tool for the early detection of AD pathology. This study aims to evaluate the proteomic profile of pEVs from patients with MCI and AD dementia to explore their potential as AD screening tools.\n                  <bold>Methods:<\/bold>\n                  pEVs were isolated by ultracentrifugation from 144 patients with MCI A-T-, MCI A+T+, and AD dementia.  Nanoparticle tracking analysis and cryo-TEM were used to characterize the pEVs. CSF, serum and pEVs proteomics were carried out by using the multiplex PEA technology of Olink\n                  <sup>\u00ae<\/sup>\n                  proteomics, Inflammation and Neurology Explore 384 panels (768 proteins).\n                  <bold>Results:<\/bold>\n                  Characterization results showed that isolated plasma fraction corresponded in shape, size and concentration to EVs. Many pEVs neurology proteins involved in AD pathology significantly correlated (r &gt; \u00b1 0.30, p &lt; 0.05) with their CSF homonyms, but not with their serum\u2019s. pEVs\u2019 proteome correlated with common AD signatures (CSF A\u03b242 and pTau181, plasma pTau181, MMSE, NBACE, and Qalb) showing similar patterns to those observed with CSF biomarkers. Several pEVs neurology proteins didn\u2019t exhibit differences between the MCI A+T+ and AD dementia groups, whilst they did with MCI A-T-. Proteins in pEVs showed strong correlations with several measures of brain atrophy in MRI. Several neurology pEV proteins predicted conversion from MCI to AD dementia. Moreover, some of these showed a significant diagnostic accuracy of AD pathology.\n                  <bold>Conclusion:<\/bold>\n                  Preliminary results suggest that EVs biomarker signature could reflect AD pathology in the prodromal stages of AD continuum. However, further experiments are still needed for a better understanding of EVs\u2019 role in AD development and pathology dissemination.\n                <\/p>","DOI":"10.21203\/rs.3.rs-7847549\/v1","type":"posted-content","created":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T11:46:56Z","timestamp":1761997616000},"source":"Crossref","is-referenced-by-count":1,"title":["A peripheral proteomic signature of Alzheimer\u2019s disease is identified in the plasma extracellular vesicles of mild cognitive impairment patients from a memory clinic: the BIOPEXAL study"],"prefix":"10.21203","author":[{"given":"Maria","family":"Capdevila-Bayo","sequence":"first","affiliation":[{"name":"Research Center and Memory Clinic. Ace Alzheimer Center Barcelona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanna","family":"Rossi","sequence":"additional","affiliation":[{"name":"Biosensing and Bioanalysis Group, Institute of Biotechnology and Biomedicine, Universitat Aut\u00f2noma de Barcelona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itziar","family":"de Rojas","sequence":"additional","affiliation":[{"name":"Research Center and Memory Clinic. Ace Alzheimer Center Barcelona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Puerta","sequence":"additional","affiliation":[{"name":"Research Center and Memory Clinic. Ace Alzheimer Center Barcelona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Guzm\u00e1n","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Science, Universitat de Barcelona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Carrasco","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Science, Universitat de Barcelona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro","family":"Mu\u00f1oz-Morales","sequence":"additional","affiliation":[{"name":"Research Center and Memory Clinic. Ace Alzheimer Center Barcelona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Oliv\u00e9","sequence":"additional","affiliation":[{"name":"Research Center and Memory Clinic. Ace Alzheimer Center Barcelona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Montrreal","sequence":"additional","affiliation":[{"name":"Research Center and Memory Clinic. Ace Alzheimer Center Barcelona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Garc\u00eda-Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Research Center and Memory Clinic. Ace Alzheimer Center Barcelona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Bay\u00f3n-Buj\u00e1n","sequence":"additional","affiliation":[{"name":"Research Center and Memory Clinic. Ace Alzheimer Center Barcelona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Miguel-Romero","sequence":"additional","affiliation":[{"name":"Research Center and Memory Clinic. Ace Alzheimer Center Barcelona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berta","family":"Calm","sequence":"additional","affiliation":[{"name":"Research Center and Memory Clinic. Ace Alzheimer Center Barcelona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Sotolongo-Grau","sequence":"additional","affiliation":[{"name":"Research Center and Memory Clinic. Ace Alzheimer Center Barcelona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adelina","family":"Orellana","sequence":"additional","affiliation":[{"name":"Research Center and Memory Clinic. Ace Alzheimer Center Barcelona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Tatinya","sequence":"additional","affiliation":[{"name":"Research Center and Memory Clinic. Ace Alzheimer Center Barcelona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Research Center and Memory Clinic. Ace Alzheimer Center Barcelona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Alegret","sequence":"additional","affiliation":[{"name":"Research Center and Memory Clinic. Ace Alzheimer Center Barcelona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Sanz-Cartagena","sequence":"additional","affiliation":[{"name":"Research Center and Memory Clinic. Ace Alzheimer Center Barcelona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00aa Victoria","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Research Center and Memory Clinic. Ace Alzheimer Center Barcelona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Marqui\u00e9","sequence":"additional","affiliation":[{"name":"Research Center and Memory Clinic. Ace Alzheimer Center Barcelona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergi","family":"Valero","sequence":"additional","affiliation":[{"name":"Research Center and Memory Clinic. Ace Alzheimer Center Barcelona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Montalb\u00e1n","sequence":"additional","affiliation":[{"name":"Research Center and Memory Clinic. Ace Alzheimer Center Barcelona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Camins","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Science, Universitat de Barcelona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Ram\u00edrez","sequence":"additional","affiliation":[{"name":"Division of Neurogenetics and Molecular Psychiatry, Department of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital Cologne, University of Cologne"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc\u00e8","family":"Mart\u00ed","sequence":"additional","affiliation":[{"name":"Grup de Sensors i Biosensors, Departament de Qu\u00edmica, Universitat Aut\u00f2noma de Barcelona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00aa Isabel","family":"Pividori","sequence":"additional","affiliation":[{"name":"Biosensing and Bioanalysis Group, Institute of Biotechnology and Biomedicine, Universitat Aut\u00f2noma de Barcelona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merc\u00e8","family":"Boada","sequence":"additional","affiliation":[{"name":"Research Center and Memory Clinic. Ace Alzheimer Center Barcelona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agustin","family":"Ruiz","sequence":"additional","affiliation":[{"name":"Research Center and Memory Clinic. Ace Alzheimer Center Barcelona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miren","family":"Ettcheto","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Science, Universitat de Barcelona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Cano","sequence":"additional","affiliation":[{"name":"Research Center and Memory Clinic. Ace Alzheimer Center Barcelona"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/alz.12694","article-title":"Global estimates on the number of persons across the Alzheimer\u2019s disease continuum","volume":"19","author":"Gustavsson A","year":"2023","unstructured":"Gustavsson A, Norton N, Fast T, Fr\u00f6lich L, Georges J, Holzapfel D, et al. Global estimates on the number of persons across the Alzheimer\u2019s disease continuum. Alzheimers Dement J Alzheimers Assoc. 2023;19:658\u201370. https:\/\/doi.org\/10.1002\/alz.12694.","journal-title":"Alzheimers Dement J Alzheimers Assoc"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/S1474-4422(24)00038-3","article-title":"Global, regional, and national burden of disorders affecting the nervous system, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"23","author":"Steinmetz JD","year":"2024","unstructured":"Steinmetz JD, Seeher KM, Schiess N, Nichols E, Cao B, Servili C, et al. Global, regional, and national burden of disorders affecting the nervous system, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol. 2024;23:344\u201381. https:\/\/doi.org\/10.1016\/S1474-4422(24)00038-3.","journal-title":"Lancet Neurol"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"2024 Alzheimer\u2019s disease facts and figures. Alzheimers Dement J Alzheimers Assoc 2024;20:3708\u2013821. https:\/\/doi.org\/10.1002\/alz.13809","DOI":"10.1002\/alz.13809"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","article-title":"National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease","volume":"8","author":"Hyman BT","year":"2012","unstructured":"Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC, et al. National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease. Alzheimers Dement J Alzheimers Assoc. 2012;8:1\u201313. https:\/\/doi.org\/10.1016\/j.jalz.2011.10.007.","journal-title":"Alzheimers Dement J Alzheimers Assoc"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","article-title":"The neuropathological diagnosis of Alzheimer\u2019s disease","volume":"14","author":"DeTure MA","year":"2019","unstructured":"DeTure MA, Dickson DW. The neuropathological diagnosis of Alzheimer\u2019s disease. Mol Neurodegener. 2019;14:32. https:\/\/doi.org\/10.1186\/s13024-019-0333-5.","journal-title":"Mol Neurodegener"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13195-022-01055-y","article-title":"Perspectives and challenges in patient stratification in Alzheimer\u2019s disease","volume":"14","author":"Abdelnour C","year":"2022","unstructured":"Abdelnour C, Agosta F, Bozzali M, Foug\u00e8re B, Iwata A, Nilforooshan R, et al. Perspectives and challenges in patient stratification in Alzheimer\u2019s disease. Alzheimers Res Ther. 2022;14:112. https:\/\/doi.org\/10.1186\/s13195-022-01055-y.","journal-title":"Alzheimers Res Ther"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"371","DOI":"10.14283\/jpad.2021.23","article-title":"Diagnosis of Early Alzheimer\u2019s Disease: Clinical Practice in 2021","volume":"8","author":"Porsteinsson AP","year":"2021","unstructured":"Porsteinsson AP, Isaacson RS, Knox S, Sabbagh MN, Rubino I. Diagnosis of Early Alzheimer\u2019s Disease: Clinical Practice in 2021. J Prev Alzheimers Dis. 2021;8:371\u201386. https:\/\/doi.org\/10.14283\/jpad.2021.23.","journal-title":"J Prev Alzheimers Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105345","article-title":"Clinical value of plasma pTau181 to predict Alzheimer\u2019s disease pathology in a large real-world cohort of a memory clinic","author":"Cano A","unstructured":"Cano A, Capdevila M, Puerta R, Arranz J, Montrreal L, de Rojas I et al. Clinical value of plasma pTau181 to predict Alzheimer\u2019s disease pathology in a large real-world cohort of a memory clinic. EBioMedicine 2024;108. https:\/\/doi.org\/10.1016\/j.ebiom.2024.105345"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"105650","DOI":"10.1016\/j.archger.2024.105650","article-title":"Novel plasma protein biomarkers: A time-dependent predictive model for Alzheimer\u2019s disease","volume":"129","author":"Zhuang T","year":"2025","unstructured":"Zhuang T, Yang Y, Ren H, Zhang H, Gao C, Chen S, et al. Novel plasma protein biomarkers: A time-dependent predictive model for Alzheimer\u2019s disease. Arch Gerontol Geriatr. 2025;129:105650. https:\/\/doi.org\/10.1016\/j.archger.2024.105650.","journal-title":"Arch Gerontol Geriatr"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"e14535","DOI":"10.1002\/alz.14535","article-title":"Novel plasma biomarkers of amyloid plaque pathology and cortical thickness: Evaluation of the NULISA targeted proteomic platform in an ethnically diverse cohort","volume":"21","author":"Zeng X","year":"2025","unstructured":"Zeng X, Sehrawat A, Lafferty TK, Chen Y, Rawat M, Kamboh MI, et al. Novel plasma biomarkers of amyloid plaque pathology and cortical thickness: Evaluation of the NULISA targeted proteomic platform in an ethnically diverse cohort. Alzheimers Dement. 2025;21:e14535. https:\/\/doi.org\/10.1002\/alz.14535.","journal-title":"Alzheimers Dement"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"721","DOI":"10.7150\/ijbs.79063","article-title":"Extracellular vesicles, the emerging mirrors of brain physiopathology","volume":"19","author":"Cano A","year":"2023","unstructured":"Cano A, Ettcheto M, Bernuz M, Puerta R, Esteban de Antonio E, S\u00e1nchez-L\u00f3pez E, et al. Extracellular vesicles, the emerging mirrors of brain physiopathology. Int J Biol Sci. 2023;19:721\u201343. https:\/\/doi.org\/10.7150\/ijbs.79063.","journal-title":"Int J Biol Sci"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"114183","DOI":"10.1016\/j.expneurol.2022.114183","article-title":"Extracellular vesicles and Alzheimer\u2019s disease in the novel era of Precision Medicine: implications for disease progression, diagnosis and treatment","volume":"358","author":"Gomes P","year":"2022","unstructured":"Gomes P, Tzouanou F, Skolariki K, Vamvaka-Iakovou A, Noguera-Ortiz C, Tsirtsaki K, et al. Extracellular vesicles and Alzheimer\u2019s disease in the novel era of Precision Medicine: implications for disease progression, diagnosis and treatment. Exp Neurol. 2022;358:114183. https:\/\/doi.org\/10.1016\/j.expneurol.2022.114183.","journal-title":"Exp Neurol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s44400-024-00002-y","article-title":"Alzheimer\u2019s disease and related dementias diagnosis: a biomarkers meta-analysis of general and CNS extracellular vesicles","volume":"1","author":"Taha HB","year":"2025","unstructured":"Taha HB. Alzheimer\u2019s disease and related dementias diagnosis: a biomarkers meta-analysis of general and CNS extracellular vesicles. Npj Dement. 2025;1:1\u201335. https:\/\/doi.org\/10.1038\/s44400-024-00002-y.","journal-title":"Npj Dement"},{"key":"ref14","volume-title":"Extracellular vesicles for the diagnosis of alzheimer\u2019s disease","author":"Pasternak S","year":"2024","unstructured":"Pasternak S, LEONG H. Extracellular vesicles for the diagnosis of alzheimer\u2019s disease. WO2024108311A1; 2024."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"eaau6977","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri R","year":"2020","unstructured":"Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367:eaau6977. https:\/\/doi.org\/10.1126\/science.aau6977.","journal-title":"Science"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13578-019-0282-2","article-title":"Exosomes: biogenesis, biologic function and clinical potential","volume":"9","author":"Zhang Y","year":"2019","unstructured":"Zhang Y, Liu Y, Liu H, Tang WH. Exosomes: biogenesis, biologic function and clinical potential. Cell Biosci. 2019;9:19. https:\/\/doi.org\/10.1186\/s13578-019-0282-2.","journal-title":"Cell Biosci"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12987-022-00359-3","article-title":"Extracellular vesicles through the blood\u2013brain barrier: a review","volume":"19","author":"Ramos-Zald\u00edvar HM","year":"2022","unstructured":"Ramos-Zald\u00edvar HM, Polakovicova I, Salas-Huenuleo E, Corval\u00e1n AH, Kogan MJ, Yefi CP, et al. Extracellular vesicles through the blood\u2013brain barrier: a review. Fluids Barriers CNS. 2022;19:60. https:\/\/doi.org\/10.1186\/s12987-022-00359-3.","journal-title":"Fluids Barriers CNS"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1096\/fj.201700731R","article-title":"Declining levels of functionally specialized synaptic proteins in plasma neuronal exosomes with progression of Alzheimer\u2019s disease","volume":"32","author":"Goetzl EJ","year":"2018","unstructured":"Goetzl EJ, Abner EL, Jicha GA, Kapogiannis D, Schwartz JB. Declining levels of functionally specialized synaptic proteins in plasma neuronal exosomes with progression of Alzheimer\u2019s disease. FASEB J Off Publ Fed Am Soc Exp Biol. 2018;32:888\u201393. https:\/\/doi.org\/10.1096\/fj.201700731R.","journal-title":"FASEB J Off Publ Fed Am Soc Exp Biol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/nm.4443","article-title":"Amyloid-\u03b2 plaques enhance Alzheimer\u2019s brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation","volume":"24","author":"He Z","year":"2018","unstructured":"He Z, Guo JL, McBride JD, Narasimhan S, Kim H, Changolkar L, et al. Amyloid-\u03b2 plaques enhance Alzheimer\u2019s brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation. Nat Med. 2018;24:29\u201338. https:\/\/doi.org\/10.1038\/nm.4443.","journal-title":"Nat Med"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1093\/brain\/awaa376","article-title":"Alzheimer\u2019s disease brain-derived extracellular vesicles spread tau pathology in interneurons","volume":"144","author":"Ruan Z","year":"2020","unstructured":"Ruan Z, Pathak D, Kalavai SV, Yoshii-Kitahara A, Muraoka S, Bhatt N, et al. Alzheimer\u2019s disease brain-derived extracellular vesicles spread tau pathology in interneurons. Brain. 2020;144:288\u2013309. https:\/\/doi.org\/10.1093\/brain\/awaa376.","journal-title":"Brain"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"e70006","DOI":"10.1002\/dad2.70006","article-title":"Assessing Alzheimer\u2019s disease via plasma extracellular vesicle\u2013derived mRNA","volume":"16","author":"Pham LHP","year":"2024","unstructured":"Pham LHP, Chang C-F, Tuchez K, Liu F, Chen Y. Assessing Alzheimer\u2019s disease via plasma extracellular vesicle\u2013derived mRNA. Alzheimers Dement Diagn Assess Dis Monit. 2024;16:e70006. https:\/\/doi.org\/10.1002\/dad2.70006.","journal-title":"Alzheimers Dement Diagn Assess Dis Monit"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jalz.2013.03.006","article-title":"Design of a comprehensive Alzheimer\u2019s disease clinic and research center in Spain to meet critical patient and family needs","volume":"10","author":"Boada M","year":"2014","unstructured":"Boada M, T\u00e1rraga L, Hern\u00e1ndez I, Valero S, Alegret M, Ruiz A, et al. Design of a comprehensive Alzheimer\u2019s disease clinic and research center in Spain to meet critical patient and family needs. Alzheimers Dement. 2014;10:409\u201315.","journal-title":"Alzheimers Dement"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"769","DOI":"10.3233\/JAD-122002","article-title":"Longitudinal follow-up of 550 mild cognitive impairment patients: Evidence for large conversion to dementia rates and detection of major risk factors involved","volume":"34","author":"Espinosa A","year":"2013","unstructured":"Espinosa A, Alegret M, Valero S, Vinyes-Junqu\u00e9 G, Hern\u00e1ndez I, Maule\u00f3n A, et al. Longitudinal follow-up of 550 mild cognitive impairment patients: Evidence for large conversion to dementia rates and detection of major risk factors involved. J Alzheimers Dis. 2013;34:769\u201380.","journal-title":"J Alzheimers Dis"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.3233\/JAD-210254","article-title":"BIOFACE: A Prospective Study of Risk Factors, Cognition, and Biomarkers in a Cohort of Individuals with Early-Onset Mild Cognitive Impairment. Study Rationale and Research Protocols","volume":"83","author":"Esteban de Antonio E","year":"2021","unstructured":"Esteban de Antonio E, P\u00e9rez-Cord\u00f3n A, Gil S, Orellana A, Cano A, Alegret M, et al. BIOFACE: A Prospective Study of Risk Factors, Cognition, and Biomarkers in a Cohort of Individuals with Early-Onset Mild Cognitive Impairment. Study Rationale and Research Protocols. J Alzheimers Dis JAD. 2021;83:1233\u201349. https:\/\/doi.org\/10.3233\/JAD-210254.","journal-title":"J Alzheimers Dis JAD"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"6891","DOI":"10.3390\/ijms23136891","article-title":"Establishing In-House Cutoffs of CSF Alzheimer\u2019 s Disease Biomarkers for the AT (N) Stratification of the Alzheimer Center Barcelona Cohort","volume":"23","author":"Orellana A","year":"2022","unstructured":"Orellana A, Garc P, Valero S, Montrreal L, Rojas I, De, Hern I, et al. Establishing In-House Cutoffs of CSF Alzheimer\u2019 s Disease Biomarkers for the AT (N) Stratification of the Alzheimer Center Barcelona Cohort. Int J Mol Sci. 2022;23:6891.","journal-title":"Int J Mol Sci"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12951-023-01793-7","article-title":"Plasma extracellular vesicles reveal early molecular differences in amyloid positive patients with early \u2013 onset mild cognitive impairment","volume":"21","author":"Cano A","year":"2023","unstructured":"Cano A, Antonio EE, De, Bernuz M, Puerta R, Gonz\u00e1lez PG, Rojas I, De, et al. Plasma extracellular vesicles reveal early molecular differences in amyloid positive patients with early \u2013 onset mild cognitive impairment. J Nanobiotechnol. 2023;21:54.","journal-title":"J Nanobiotechnol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jalz.2011.07.004","article-title":"Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer\u2019s disease diagnosis: a consensus paper from the Alzheimer\u2019s Biomarkers Standardization Initiative","volume":"8","author":"Vanderstichele H","year":"2012","unstructured":"Vanderstichele H, Bibl M, Engelborghs S, Le Bastard N, Lewczuk P, Molinuevo JL, et al. Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer\u2019s disease diagnosis: a consensus paper from the Alzheimer\u2019s Biomarkers Standardization Initiative. Alzheimers Dement J Alzheimers Assoc. 2012;8:65\u201373. https:\/\/doi.org\/10.1016\/j.jalz.2011.07.004.","journal-title":"Alzheimers Dement J Alzheimers Assoc"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.jalz.2014.03.003","article-title":"The clinical use of cerebrospinal fluid biomarker testing for Alzheimer\u2019s disease diagnosis: a consensus paper from the Alzheimer\u2019s Biomarkers Standardization Initiative","volume":"10","author":"Molinuevo JL","year":"2014","unstructured":"Molinuevo JL, Blennow K, Dubois B, Engelborghs S, Lewczuk P, Perret-Liaudet A, et al. The clinical use of cerebrospinal fluid biomarker testing for Alzheimer\u2019s disease diagnosis: a consensus paper from the Alzheimer\u2019s Biomarkers Standardization Initiative. Alzheimers Dement. 2014;10:808\u201317.","journal-title":"Alzheimers Dement"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"24590","DOI":"10.18632\/oncotarget.25083","article-title":"Genome-wide significant risk factors on chromosome 19 and the APOE locus","volume":"9","author":"Moreno-Grau S","year":"2018","unstructured":"Moreno-Grau S, Hern\u00e1ndez I, Heilmann-Heimbach S, Ruiz S, Rosende-Roca M, Maule\u00f3n A, et al. Genome-wide significant risk factors on chromosome 19 and the APOE locus. Oncotarget. 2018;9:24590\u2013600. https:\/\/doi.org\/10.18632\/oncotarget.25083.","journal-title":"Oncotarget"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.1038\/s41467-021-22491-8","article-title":"Common variants in Alzheimer\u2019s disease and risk stratification by polygenic risk scores","volume":"12","author":"Rojas I","year":"2021","unstructured":"de Rojas I, Moreno-Grau S, Tesi N, Grenier-Boley B, Andrade V, Jansen IE, et al. Common variants in Alzheimer\u2019s disease and risk stratification by polygenic risk scores. Nat Commun. 2021;12:3417. https:\/\/doi.org\/10.1038\/s41467-021-22491-8.","journal-title":"Nat Commun"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","article-title":"New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias","volume":"54","author":"Bellenguez C","year":"2022","unstructured":"Bellenguez C, K\u00fc\u00e7\u00fckali F, Jansen IE, Kleineidam L, Moreno-Grau S, Amin N, et al. New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias. Nat Genet. 2022;54:412\u201336. https:\/\/doi.org\/10.1038\/s41588-022-01024-z.","journal-title":"Nat Genet"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/ng.3538","article-title":"Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets","volume":"48","author":"Zhu Z","year":"2016","unstructured":"Zhu Z, Zhang F, Hu H, Bakshi A, Robinson MR, Powell JE, et al. Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat Genet. 2016;48:481\u20137. https:\/\/doi.org\/10.1038\/ng.3538.","journal-title":"Nat Genet"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13195-019-0550-8","article-title":"Clinical validation of the Lumipulse G cerebrospinal fluid assays for routine diagnosis of Alzheimer\u2019s disease","volume":"11","author":"Leit\u00e3o MJ","year":"2019","unstructured":"Leit\u00e3o MJ, Silva-Sp\u00ednola A, Santana I, Olmedo V, Nadal A, Bastard N, Le, et al. Clinical validation of the Lumipulse G cerebrospinal fluid assays for routine diagnosis of Alzheimer\u2019s disease. Alzheimers Res Ther. 2019;11:91.","journal-title":"Alzheimers Res Ther"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s40478-019-0795-2","article-title":"Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer \u2019 s disease","volume":"7","author":"Whelan CD","year":"2019","unstructured":"Whelan CD, Mattsson N, Nagle MW, Vijayaraghavan S, Hyde C, Janelidze S, et al. Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer \u2019 s disease. Acta Neuropathol Commun. 2019;7:169.","journal-title":"Acta Neuropathol Commun"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"e95192","DOI":"10.1371\/journal.pone.0095192","article-title":"Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability","volume":"9","author":"Assarsson E","year":"2014","unstructured":"Assarsson E, Lundberg M, Holmquist G, Bj\u00f6rkesten J, Thorsen SB, Ekman D, et al. Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability. PLoS ONE. 2014;9:e95192.","journal-title":"PLoS ONE"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42003-023-04911-1","article-title":"Lack of involvement of CD63 and CD9 tetraspanins in the extracellular vesicle content delivery process","volume":"6","author":"Tognoli ML","year":"2023","unstructured":"Tognoli ML, Dancourt J, Bonsergent E, Palmulli R, de Jong OG, Van Niel G, et al. Lack of involvement of CD63 and CD9 tetraspanins in the extracellular vesicle content delivery process. Commun Biol. 2023;6:1\u20139. https:\/\/doi.org\/10.1038\/s42003-023-04911-1.","journal-title":"Commun Biol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13195-024-01656-9","article-title":"Exploring sex differences in Alzheimer\u2019s disease: a comprehensive analysis of a large patient cohort from a memory unit","volume":"17","author":"Rosende-Roca M","year":"2025","unstructured":"Rosende-Roca M, Garc\u00eda-Guti\u00e9rrez F, Cantero-Fortiz Y, Alegret M, Pytel V, Ca\u00f1abate P, et al. Exploring sex differences in Alzheimer\u2019s disease: a comprehensive analysis of a large patient cohort from a memory unit. Alzheimers Res Ther. 2025;17:27. https:\/\/doi.org\/10.1186\/s13195-024-01656-9.","journal-title":"Alzheimers Res Ther"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s43587-023-00550-7","article-title":"Cerebrospinal fluid proteomics in patients with Alzheimer\u2019s disease reveals five molecular subtypes with distinct genetic risk profiles","volume":"4","author":"Tijms BM","year":"2024","unstructured":"Tijms BM, Vromen EM, Mjaavatten O, Holstege H, Reus LM, van der Lee S, et al. Cerebrospinal fluid proteomics in patients with Alzheimer\u2019s disease reveals five molecular subtypes with distinct genetic risk profiles. Nat Aging. 2024;4:33\u201347. https:\/\/doi.org\/10.1038\/s43587-023-00550-7.","journal-title":"Nat Aging"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"6309","DOI":"10.1016\/j.cell.2024.08.049","article-title":"CSF proteomics identifies early changes in autosomal dominant Alzheimer\u2019s disease","volume":"187","author":"Shen Y","year":"2024","unstructured":"Shen Y, Timsina J, Heo G, Beric A, Ali M, Wang C, et al. CSF proteomics identifies early changes in autosomal dominant Alzheimer\u2019s disease. Cell. 2024;187:6309\u2013e632615. https:\/\/doi.org\/10.1016\/j.cell.2024.08.049.","journal-title":"Cell"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"e9356","DOI":"10.15252\/msb.20199356","article-title":"Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer\u2019s disease","volume":"16","author":"Bader JM","year":"2020","unstructured":"Bader JM, Geyer PE, M\u00fcller JB, Strauss MT, Koch M, Leypoldt F, et al. Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer\u2019s disease. Mol Syst Biol. 2020;16:e9356. https:\/\/doi.org\/10.15252\/msb.20199356.","journal-title":"Mol Syst Biol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s13195-024-01504-w","article-title":"APP dyshomeostasis in the pathogenesis of Alzheimer\u2019s disease: implications for current drug targets","volume":"16","author":"Sirisi S","year":"2024","unstructured":"Sirisi S, S\u00e1nchez-Aced \u00c9, Belbin O, Lle\u00f3 A. APP dyshomeostasis in the pathogenesis of Alzheimer\u2019s disease: implications for current drug targets. Alzheimers Res Ther. 2024;16:144. https:\/\/doi.org\/10.1186\/s13195-024-01504-w.","journal-title":"Alzheimers Res Ther"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.3233\/JAD-220323","article-title":"Phosphatidylethanolamine Binding Protein 1 (PEBP1) in Alzheimer\u2019s Disease: ELISA Development and Clinical Validation","volume":"88","author":"Wojda\u0142a AL","year":"2022","unstructured":"Wojda\u0142a AL, Chiasserini D, Bellomo G, Paciotti S, Gaetani L, Paoletti FP, et al. Phosphatidylethanolamine Binding Protein 1 (PEBP1) in Alzheimer\u2019s Disease: ELISA Development and Clinical Validation. J Alzheimers Dis JAD. 2022;88:1459\u201368. https:\/\/doi.org\/10.3233\/JAD-220323.","journal-title":"J Alzheimers Dis JAD"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"174437","DOI":"10.1016\/j.ejphar.2021.174437","article-title":"Alzheimer\u2019s disease: Is there a role for galectins?","volume":"909","author":"Rosa MM","year":"2021","unstructured":"da Rosa MM, de Aguiar Ferreira M, de Oliveira Lima CA, Santos Mendon\u00e7a AC, Silva YM, Sharjeel M, et al. Alzheimer\u2019s disease: Is there a role for galectins? Eur J Pharmacol. 2021;909:174437. https:\/\/doi.org\/10.1016\/j.ejphar.2021.174437.","journal-title":"Eur J Pharmacol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"13576","DOI":"10.1073\/pnas.0902714106","article-title":"Overexpression of SOD-2 reduces hippocampal superoxide and prevents memory deficits in a mouse model of Alzheimer\u2019s disease","volume":"106","author":"Massaad CA","year":"2009","unstructured":"Massaad CA, Washington TM, Pautler RG, Klann E. Overexpression of SOD-2 reduces hippocampal superoxide and prevents memory deficits in a mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci U S A. 2009;106:13576\u201381. https:\/\/doi.org\/10.1073\/pnas.0902714106.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13195-018-0397-4","article-title":"Alzheimer disease pathology and the cerebrospinal fluid proteome","volume":"10","author":"Dayon L","year":"2018","unstructured":"Dayon L, N\u00fa\u00f1ez Galindo A, Wojcik J, Cominetti O, Corth\u00e9sy J, Oikonomidi A, et al. Alzheimer disease pathology and the cerebrospinal fluid proteome. Alzheimers Res Ther. 2018;10:66. https:\/\/doi.org\/10.1186\/s13195-018-0397-4.","journal-title":"Alzheimers Res Ther"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.bbi.2022.05.006","article-title":"Causal effects of circulating cytokine concentrations on risk of Alzheimer\u2019s disease and cognitive function","volume":"104","author":"Pagoni P","year":"2022","unstructured":"Pagoni P, Korologou-Linden RS, Howe LD, Davey Smith G, Ben-Shlomo Y, Stergiakouli E, et al. Causal effects of circulating cytokine concentrations on risk of Alzheimer\u2019s disease and cognitive function. Brain Behav Immun. 2022;104:54\u201364. https:\/\/doi.org\/10.1016\/j.bbi.2022.05.006.","journal-title":"Brain Behav Immun"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.3233\/JAD-2010-100717","article-title":"Deficiency of the Copper Chaperone for Superoxide Dismutase Increases Amyloid-\u03b2 Production","volume":"21","author":"Gray EH","year":"2010","unstructured":"Gray EH, De Vos KJ, Dingwall C, Perkinton MS, Miller CCJ. Deficiency of the Copper Chaperone for Superoxide Dismutase Increases Amyloid-\u03b2 Production. J Alzheimers Dis JAD. 2010;21:1101\u20135. https:\/\/doi.org\/10.3233\/JAD-2010-100717.","journal-title":"J Alzheimers Dis JAD"},{"key":"ref48","unstructured":"ADI - Dementia facts. & figures n.d. https:\/\/www.alzint.org\/about\/dementia-facts-figures\/ (accessed May 7, 2025)."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1038\/s41598-020-57497-7","article-title":"A comparison of methods for the isolation and separation of extracellular vesicles from protein and lipid particles in human serum","volume":"10","author":"Brennan K","year":"2020","unstructured":"Brennan K, Martin K, FitzGerald SP, O\u2019Sullivan J, Wu Y, Blanco A, et al. A comparison of methods for the isolation and separation of extracellular vesicles from protein and lipid particles in human serum. Sci Rep. 2020;10:1039. https:\/\/doi.org\/10.1038\/s41598-020-57497-7.","journal-title":"Sci Rep"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"e110","DOI":"10.1002\/cpcb.110","article-title":"Exosome Isolation by Ultracentrifugation and Precipitation: A Comparison of Techniques for Downstream Analyses","volume":"88","author":"Coughlan C","year":"2020","unstructured":"Coughlan C, Bruce K, Burgy O, Boyd TD, Michel CR, Garcia-Perez JE, et al. Exosome Isolation by Ultracentrifugation and Precipitation: A Comparison of Techniques for Downstream Analyses. Curr Protoc Cell Biol. 2020;88:e110. https:\/\/doi.org\/10.1002\/cpcb.110.","journal-title":"Curr Protoc Cell Biol"},{"key":"ref51","first-page":"203","article-title":"Emerging roles of exosomes in normal and pathological conditions: new insights for diagnosis and therapeutic applications","volume":"6","author":"Toro J","year":"2015","unstructured":"de Toro J, Herschlik L, Mongini C, Waldner C. Emerging roles of exosomes in normal and pathological conditions: new insights for diagnosis and therapeutic applications. Front Immunol. 2015;6:203.","journal-title":"Front Immunol"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"971","DOI":"10.3233\/JAD-180302","article-title":"Growth Hormone-Releasing Hormone Modulation of Neuronal Exosome Biomarkers in Mild Cognitive Impairment","volume":"66","author":"Winston CN","year":"2018","unstructured":"Winston CN, Goetzl EJ, Baker LD, Vitiello MV, Rissman RA. Growth Hormone-Releasing Hormone Modulation of Neuronal Exosome Biomarkers in Mild Cognitive Impairment. J Alzheimers Dis JAD. 2018;66:971\u201381. https:\/\/doi.org\/10.3233\/JAD-180302.","journal-title":"J Alzheimers Dis JAD"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12974-024-03054-2","article-title":"Inhibition of MMP8 effectively alleviates manic-like behavior and reduces neuroinflammation by modulating astrocytic CEBPD","volume":"21","author":"Wang T-Y","year":"2024","unstructured":"Wang T-Y, Weng EF-J, Hsu Y-C, Shiu L-P, Huang T-W, Wu H-C, et al. Inhibition of MMP8 effectively alleviates manic-like behavior and reduces neuroinflammation by modulating astrocytic CEBPD. J Neuroinflammation. 2024;21:61. https:\/\/doi.org\/10.1186\/s12974-024-03054-2.","journal-title":"J Neuroinflammation"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s12035-014-8860-0","article-title":"Neuroinflammatory and Amyloidogenic Activities of IL-32\u03b2 in Alzheimer\u2019s Disease","volume":"52","author":"Yun H-M","year":"2015","unstructured":"Yun H-M, Kim JA, Hwang CJ, Jin P, Baek MK, Lee JM, et al. Neuroinflammatory and Amyloidogenic Activities of IL-32\u03b2 in Alzheimer\u2019s Disease. Mol Neurobiol. 2015;52:341\u201352. https:\/\/doi.org\/10.1007\/s12035-014-8860-0.","journal-title":"Mol Neurobiol"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13041-024-01150-1","article-title":"NDRG1 upregulation by ubiquitin proteasome system dysfunction aggravates neurodegeneration","volume":"17","author":"Hoshino T","year":"2024","unstructured":"Hoshino T, Mukai A, Yamashita H, Misawa H, Urushitani M, Tashiro Y, et al. NDRG1 upregulation by ubiquitin proteasome system dysfunction aggravates neurodegeneration. Mol Brain. 2024;17:77. https:\/\/doi.org\/10.1186\/s13041-024-01150-1.","journal-title":"Mol Brain"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1177\/13872877241307337","article-title":"SMOC2 promotes microglia activity and neuroinflammation in Alzheimer\u2019s disease","volume":"103","author":"Wan T","year":"2025","unstructured":"Wan T, Wang C. SMOC2 promotes microglia activity and neuroinflammation in Alzheimer\u2019s disease. J Alzheimers Dis JAD. 2025;103:941\u201350. https:\/\/doi.org\/10.1177\/13872877241307337.","journal-title":"J Alzheimers Dis JAD"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13024-024-00757-1","article-title":"Heparin-enriched plasma proteome is significantly altered in Alzheimer\u2019s disease","volume":"19","author":"Guo Q","year":"2024","unstructured":"Guo Q, Ping L, Dammer EB, Duong DM, Yin L, Xu K, et al. Heparin-enriched plasma proteome is significantly altered in Alzheimer\u2019s disease. Mol Neurodegener. 2024;19:67. https:\/\/doi.org\/10.1186\/s13024-024-00757-1.","journal-title":"Mol Neurodegener"},{"key":"ref58","unstructured":"HLA-DRA protein expression summary. - The Human Protein Atlas n.d. https:\/\/www.proteinatlas.org\/ENSG00000204287-HLA-DRA (accessed May 7, 2025)."},{"key":"ref59","unstructured":"PRSS8 protein expression summary - The Human Protein. Atlas n.d. https:\/\/www.proteinatlas.org\/ENSG00000052344-PRSS8 (accessed May 7, 2025)."},{"key":"ref60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbi.2012.11.006","article-title":"IL-1 receptor 2 (IL-1R2) and its role in immune regulation","volume":"32","author":"Peters VA","year":"2013","unstructured":"Peters VA, Joesting JJ, Freund GG. IL-1 receptor 2 (IL-1R2) and its role in immune regulation. Brain Behav Immun. 2013;32:1\u20138. https:\/\/doi.org\/10.1016\/j.bbi.2012.11.006.","journal-title":"Brain Behav Immun"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s00401-020-02261-4","article-title":"The proteome of granulovacuolar degeneration and neurofibrillary tangles in Alzheimer\u2019s disease","volume":"141","author":"Hondius DC","year":"2021","unstructured":"Hondius DC, Koopmans F, Leistner C, Pita-Illobre D, Peferoen-Baert RM, Marbus F, et al. The proteome of granulovacuolar degeneration and neurofibrillary tangles in Alzheimer\u2019s disease. Acta Neuropathol (Berl). 2021;141:341\u201358. https:\/\/doi.org\/10.1007\/s00401-020-02261-4.","journal-title":"Acta Neuropathol (Berl)"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s41983-023-00751-2","article-title":"Akt signaling pathway: a potential therapy for Alzheimer\u2019s disease through glycogen synthase kinase 3 beta inhibition","volume":"59","author":"Limantoro J","year":"2023","unstructured":"Limantoro J, de Liyis BG, Sutedja JC. Akt signaling pathway: a potential therapy for Alzheimer\u2019s disease through glycogen synthase kinase 3 beta inhibition. Egypt J Neurol Psychiatry Neurosurg. 2023;59:147. https:\/\/doi.org\/10.1186\/s41983-023-00751-2.","journal-title":"Egypt J Neurol Psychiatry Neurosurg"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"768655","DOI":"10.3389\/fncel.2021.768655","article-title":"Exploration of Aberrant E3 Ligases Implicated in Alzheimer\u2019s Disease and Development of Chemical Tools to Modulate Their Function","volume":"15","author":"Potjewyd FM","year":"2021","unstructured":"Potjewyd FM, Axtman AD. Exploration of Aberrant E3 Ligases Implicated in Alzheimer\u2019s Disease and Development of Chemical Tools to Modulate Their Function. Front Cell Neurosci. 2021;15:768655. https:\/\/doi.org\/10.3389\/fncel.2021.768655.","journal-title":"Front Cell Neurosci"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"113481","DOI":"10.1016\/j.bbr.2021.113481","article-title":"Role of RhoA\/ROCK signaling in Alzheimer\u2019s disease","volume":"414","author":"Cai R","year":"2021","unstructured":"Cai R, Wang Y, Huang Z, Zou Q, Pu Y, Yu C, et al. Role of RhoA\/ROCK signaling in Alzheimer\u2019s disease. Behav Brain Res. 2021;414:113481. https:\/\/doi.org\/10.1016\/j.bbr.2021.113481.","journal-title":"Behav Brain Res"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13024-021-00489-6","article-title":"Nuclear dynamics and stress responses in Alzheimer\u2019s disease","volume":"16","author":"Iatrou A","year":"2021","unstructured":"Iatrou A, Clark EM, Wang Y. Nuclear dynamics and stress responses in Alzheimer\u2019s disease. Mol Neurodegener. 2021;16:65. https:\/\/doi.org\/10.1186\/s13024-021-00489-6.","journal-title":"Mol Neurodegener"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3233\/JAD-2012-111850","article-title":"A two-year follow-up of cognitive deficits and brain perfusion in mild cognitive impairment and mild Alzheimer\u2019s disease","volume":"30","author":"Alegret M","year":"2012","unstructured":"Alegret M, Cuberas-Borr\u00f3s G, Vinyes-Junqu\u00e9 G, Espinosa A, Valero S, Hern\u00e1ndez I, et al. A two-year follow-up of cognitive deficits and brain perfusion in mild cognitive impairment and mild Alzheimer\u2019s disease. J Alzheimers Dis JAD. 2012;30:109\u201320. https:\/\/doi.org\/10.3233\/JAD-2012-111850.","journal-title":"J Alzheimers Dis JAD"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41577-024-01104-7","article-title":"Neuroinflammation in Alzheimer disease","volume":"25","author":"Heneka MT","year":"2025","unstructured":"Heneka MT, van der Flier WM, Jessen F, Hoozemanns J, Thal DR, Boche D, et al. Neuroinflammation in Alzheimer disease. Nat Rev Immunol. 2025;25:321\u201352. https:\/\/doi.org\/10.1038\/s41577-024-01104-7.","journal-title":"Nat Rev Immunol"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1093\/brain\/awn146","article-title":"Ventricular enlargement as a possible measure of Alzheimer\u2019s disease progression validated using the Alzheimer\u2019s disease neuroimaging initiative database","volume":"131","author":"Nestor SM","year":"2008","unstructured":"Nestor SM, Rupsingh R, Borrie M, Smith M, Accomazzi V, Wells JL, et al. Ventricular enlargement as a possible measure of Alzheimer\u2019s disease progression validated using the Alzheimer\u2019s disease neuroimaging initiative database. Brain. 2008;131:2443\u201354. https:\/\/doi.org\/10.1093\/brain\/awn146.","journal-title":"Brain"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jocn.2016.05.038","article-title":"Total intracranial and lateral ventricle volumes measurement in Alzheimer\u2019s disease: A methodological study","volume":"34","author":"Ertekin T","year":"2016","unstructured":"Ertekin T, Acer N, K\u00f6seo\u011flu E, Zarars\u0131z G, S\u00f6nmez A, G\u00fcm\u00fc\u015f K, et al. Total intracranial and lateral ventricle volumes measurement in Alzheimer\u2019s disease: A methodological study. J Clin Neurosci Off J Neurosurg Soc Australas. 2016;34:133\u20139. https:\/\/doi.org\/10.1016\/j.jocn.2016.05.038.","journal-title":"J Clin Neurosci Off J Neurosurg Soc Australas"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1212\/WNL.0000000000004688","article-title":"Midlife systemic inflammatory markers are associated with late-life brain volume: The ARIC study","volume":"89","author":"Walker KA","year":"2017","unstructured":"Walker KA, Hoogeveen RC, Folsom AR, Ballantyne CM, Knopman DS, Windham BG, et al. Midlife systemic inflammatory markers are associated with late-life brain volume: The ARIC study. Neurology. 2017;89:2262\u201370. https:\/\/doi.org\/10.1212\/WNL.0000000000004688.","journal-title":"Neurology"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/2045-8118-8-12","article-title":"Cerebrospinal fluid and blood flow in mild cognitive impairment and Alzheimer\u2019s disease: a differential diagnosis from idiopathic normal pressure hydrocephalus","volume":"8","author":"Sankari S","year":"2011","unstructured":"El Sankari S, Gondry-Jouet C, Fichten A, Godefroy O, Serot JM, Deramond H, et al. Cerebrospinal fluid and blood flow in mild cognitive impairment and Alzheimer\u2019s disease: a differential diagnosis from idiopathic normal pressure hydrocephalus. Fluids Barriers CNS. 2011;8:12. https:\/\/doi.org\/10.1186\/2045-8118-8-12.","journal-title":"Fluids Barriers CNS"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12987-022-00318-y","article-title":"Decreased CSF clearance and increased brain amyloid in Alzheimer\u2019s disease","volume":"19","author":"Li Y","year":"2022","unstructured":"Li Y, Rusinek H, Butler T, Glodzik L, Pirraglia E, Babich J, et al. Decreased CSF clearance and increased brain amyloid in Alzheimer\u2019s disease. Fluids Barriers CNS. 2022;19:21. https:\/\/doi.org\/10.1186\/s12987-022-00318-y.","journal-title":"Fluids Barriers CNS"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","article-title":"Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?","volume":"17","author":"Leng F","year":"2021","unstructured":"Leng F, Edison P. Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? Nat Rev Neurol. 2021;17:157\u201372. https:\/\/doi.org\/10.1038\/s41582-020-00435-y.","journal-title":"Nat Rev Neurol"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"475a","DOI":"10.1016\/j.bpj.2022.11.2547","article-title":"Elucidating the role of nucleophosmin in protein quality control mechanisms inside the nucleolus","volume":"122","author":"Maslanka C","year":"2023","unstructured":"Maslanka C, Dogra P, Tripathi S, Phillips AH, Kriwacki R. Elucidating the role of nucleophosmin in protein quality control mechanisms inside the nucleolus. Biophys J. 2023;122:475a. https:\/\/doi.org\/10.1016\/j.bpj.2022.11.2547.","journal-title":"Biophys J"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-7847549\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-7847549\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T16:04:20Z","timestamp":1789401860000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-7847549\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,1]]},"references-count":74,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-7847549\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1186\/s12951-026-04952-8","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2025,11,1]]},"subtype":"preprint"}}